(NYSE: NGVT) Ingevity's forecast annual revenue growth rate of 2.24% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.99%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.34%.
Ingevity's revenue in 2026 is $1,167,600,000.On average, 6 Wall Street analysts forecast NGVT's revenue for 2026 to be $42,914,930,944, with the lowest NGVT revenue forecast at $40,373,915,296, and the highest NGVT revenue forecast at $45,385,362,824. On average, 6 Wall Street analysts forecast NGVT's revenue for 2027 to be $42,950,222,828, with the lowest NGVT revenue forecast at $35,035,664,922, and the highest NGVT revenue forecast at $47,255,832,676.
In 2028, NGVT is forecast to generate $43,373,725,436 in revenue, with the lowest revenue forecast at $35,997,721,680 and the highest revenue forecast at $48,349,881,080.